Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access.

This topic was the focus of a breakout session at Outcomes+ 2022.

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.

This topic was the focus of a breakout session at Outcomes+ 2022.

Taking a whole-person approach to care leads to healthier people and more affordable plans.

A clinically based, expertly evaluated platform of digital health solutions to address your plan’s most pressing challenges. Each solution on the Evernorth Digital Health Formulary has been clinically reviewed and evaluated through our streamlined and rigorous review process.